Alopecia Areata Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People of any gender aged 18 or older
• People with any skin tone (Fitzpatrick Skin Types I through VI are all included)
• People who have been clinically diagnosed with FFA (frontal fibrosing alopecia) with small bumps on the face (facial papules)
• People who are able to read, speak, and understand English or Spanish, and who are able to sign a consent form
• People who are willing and able to attend all scheduled treatment and follow-up appointments and follow care instructions before and after treatment
• People who have no medical reason to avoid laser therapy
• People who are willing to have photos taken of the treatment area and agree to those photos being used for presentations, education, or marketing
• People who agree not to have any other procedures or start any new treatments on the treatment area during the study
• People who are willing to use skincare products and follow a skincare routine approved by the study investigator throughout the study

Who may not be able to join:

• People who received treatment to the target area in another clinical trial within the past 30 days
• People who had certain treatments to the target area within the past 3 months, including chemical peels, dermabrasion, microneedling, radiofrequency treatment, laser or light-based procedures, freezing or chemical destruction of tissue, steroid injections into a lesion, photodynamic therapy, or acne surgery
• People who had botulinum toxin (such as Botox) injected into the target area within the past 3 months, or who plan to do so during the study
• People who have taken oral retinoid medications (such as isotretinoin/Accutane) within the past 3 months
• People whose skin in the target area is still healing from a previous treatment, as determined by the study investigator
• People with a history of cancerous tumours in the target area
• People who are pregnant, breastfeeding, or planning to become pregnant during the study
• People who have a diagnosed condition affecting the immune system, or who are currently taking medications that suppress the immune system
• People with a diagnosed connective tissue disease, such as lupus or scleroderma
• People taking any medication known to increase sensitivity to light, as determined by the study investigator
• People with a history of heat-triggered conditions such as recurring cold sores or shingles in the target area, unless a preventive treatment plan is in place (confirm with trial site)
• People who have had radiation to the target area, are currently being treated for skin cancer in the target area, or are undergoing chemotherapy for cancer
• People with a diagnosed pigment disorder (such as vitiligo) in the target area
• People who are heavily tanned in the treatment area, or who are unlikely to avoid tanning in that area during the study
• People with a history of keloid or raised, thickened scarring
• People who are currently incarcerated
• People whose physical, mental, or medical condition may make participation unsafe or interfere with the study, as determined by the study investigator

Important: Always verify eligibility with the trial site directly before applying.